1. ICER says AbbVie’s Rinvoq for RA may be cost-effective but still questions the value of JAK class — Gilead, Galapagos share 52-week update on filgotinib — UPS gets clearance to expand medical drone delivery service across US — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

High Volume reps leaving / fired

Discussion in 'Wright Medical' started by anonymous, Aug 26, 2019 at 8:12 PM.

  1. anonymous

    anonymous Guest

    That's not what I'm hearing.
     
  2. anonymous

    anonymous Guest

    Let's wait for the survey results and see if his name pops up.
     
  3. anonymous

    anonymous Guest

  4. anonymous

    anonymous Guest

    No, great dude.
     
  5. anonymous

    anonymous Guest

    Barry would mop the shop floor with your azz, you hillbilly .
     
  6. anonymous

    anonymous Guest

  7. anonymous

    anonymous Guest

    BR can eat a rotten sausage
     
  8. anonymous

    anonymous Guest

    Spent a ton of money with nothing to show.....

    Tick Tock.
     
  9. anonymous

    anonymous Guest

    BR is sleeping with so and so just saying!! I wanted everyone to know anonymously
     
  10. anonymous

    anonymous Guest

    ^^this^^
     
  11. anonymous

    anonymous Guest

    ^^Fired Fool^^
     
  12. anonymous

    anonymous Guest

    I suspect PET Project costs are higher that savings generated.
     
  13. anonymous

    anonymous Guest

    You read the quarterly report right, better EPS than expected even missing revenue you think that came from what other than Ops efficiency?